Skip to main content

Advertising Disclaimer »

Main menu

  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers
  • Other Publications
    • American Academy of Pediatrics

User menu

  • Log in

Search

  • Advanced search
American Academy of Pediatrics

AAP Gateway

Advanced Search

AAP Logo

  • Log in
  • Journals
    • Pediatrics
    • Hospital Pediatrics
    • Pediatrics in Review
    • NeoReviews
    • AAP Grand Rounds
    • AAP News
  • Authors/Reviewers
    • Submit Manuscript
    • Author Guidelines
    • Reviewer Guidelines
    • Open Access
    • Editorial Policies
  • Content
    • Current Issue
    • Online First
    • Archive
    • Blogs
    • Topic/Program Collections
    • AAP Meeting Abstracts
  • Pediatric Collections
    • COVID-19
    • Racism and Its Effects on Pediatric Health
    • More Collections...
  • AAP Policy
  • Supplements
  • Multimedia
    • Video Abstracts
    • Pediatrics On Call Podcast
  • Subscribe
  • Alerts
  • Careers

Discover Pediatric Collections on COVID-19 and Racism and Its Effects on Pediatric Health

American Academy of Pediatrics
SUPPLEMENT

Preface

Claude Earl Fox, Michele A. Lloyd-Puryear and Marie Mann
Pediatrics August 2000, 106 (Supplement 2) 383;
Claude Earl Fox
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michele A. Lloyd-Puryear
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marie Mann
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • Comments
Loading
Download PDF

Each year the 4 million infants born in the United States are screened shortly after birth to detect a variety of congenital conditions. These public health screening programs have become models for population-based screening. Newborn screening programs in this country began with the work of Dr Robert Guthrie in the 1960s with the development of a screening test for phenylketonuria (PKU). Today, all states screen for a wide range of conditions. However, the array of screening tests performed by each state varies and changes periodically. The variability reflects differences in community values, in state political and economic environments, and in technical capabilities.

The Health Resources and Services Administration's (HRSA) Maternal and Child Health programs have supported the development of these programs from their inception. HRSA funded the early work of Dr Guthrie to develop the screening test for PKU, sponsored cost-effectiveness studies for the PKU screening test, and facilitated the expansion of newborn screening programs to include screening tests for sickle cell anemia. In recognition of this historical involvement with state newborn screening programs, HRSA requested the American Academy of Pediatrics (AAP) to convene The Task Force on Newborn Screening. Genuine concern for the health of infants and children demands a periodic assessment of health service programs such as newborn screening so that these programs can provide better service. The Task Force on Newborn Screening addresses this responsibility in a thoughtful and comprehensive manner. The charge to the Task Force was to review and evaluate the issues and challenges facing the nation's newborn screening programs and to make recommendations to strengthen these programs. This Task Force has appropriately involved many groups and individuals from within and outside the newborn screening, pediatrics, and genetics communities, representing a diversity of views and expertise.

The Task Force recommendations were developed with recognition that the environmental context within which these programs were established has changed dramatically over the past 10 years. The growing impact of consumer advocacy has resulted in a congressional directive to federal agencies to expand and evaluate newborn screening programs. New technologies such as tandem mass spectrometry and DNA-based tests offer the possibility for screening for additional conditions. Changing demographics emphasize the importance of understanding the cultural uniqueness in approaches to health. The Human Genome Project provides the basis for understanding variations in risk among individuals for medically important and genetically complex human diseases. This project brings new understandings about race and ethnicity. The advances in basic and clinical science and technology resulting from the Human Genome Project will offer unparalleled promise to improve abilities to promote health and prevent, diagnose, and treat diseases in children. Not to be forgotten will be those essential ethical, legal, and social questions that must be addressed as well as the challenge in balancing the need to both protect a population's health and to respect individual rights. Further, with the advent of new technologies and new knowledge, it is critical that the newborn screening programs continue to operate under sound public health principles and are connected to medical homes to provide care that is accessible, family-centered, continuous, comprehensive, coordinated, compassionate, and culturally competent.

The task of proposing changes to meet the challenges of the 21st century, while preserving the accomplishments of the past, has been undertaken with objectivity, sensitivity, and creativity by the newborn screening, pediatric, and genetics communities. One outcome of this process is the report published here. It will provide a basis for constructive dialogue and for setting a national agenda for progress.

The HRSA wishes to thank the Task Force and members of the workgroups for their hard work and their commitment to this process. We also wish to recognize the leadership that the AAP brought to the success of this process. Finally, we would like to acknowledge Linda L. McCabe, PhD, for her skillful editing of this report.

PreviousNext
Back to top

Advertising Disclaimer »

In this issue

Pediatrics
Vol. 106, Issue Supplement 2
1 Aug 2000
  • Table of Contents
  • Index by author
View this article with LENS
PreviousNext
Email Article

Thank you for your interest in spreading the word on American Academy of Pediatrics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Preface
(Your Name) has sent you a message from American Academy of Pediatrics
(Your Name) thought you would like to see the American Academy of Pediatrics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Request Permissions
Article Alerts
Log in
You will be redirected to aap.org to login or to create your account.
Or Sign In to Email Alerts with your Email Address
Citation Tools
Preface
Claude Earl Fox, Michele A. Lloyd-Puryear, Marie Mann
Pediatrics Aug 2000, 106 (Supplement 2) 383;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Preface
Claude Earl Fox, Michele A. Lloyd-Puryear, Marie Mann
Pediatrics Aug 2000, 106 (Supplement 2) 383;
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Print
Download PDF
Insight Alerts
  • Table of Contents

Jump to section

  • Article
  • Info & Metrics
  • Comments

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project
  • Google Scholar

More in this TOC Section

  • About This Synopsis Book
  • Section on Allergy and Immunology
  • A Synopsis of the Synopses, 2019–2020
Show more Supplement

Similar Articles

Subjects

  • Fetus/Newborn Infant
    • Fetus/Newborn Infant
  • Journal Info
  • Editorial Board
  • Editorial Policies
  • Overview
  • Licensing Information
  • Authors/Reviewers
  • Author Guidelines
  • Submit My Manuscript
  • Open Access
  • Reviewer Guidelines
  • Librarians
  • Institutional Subscriptions
  • Usage Stats
  • Support
  • Contact Us
  • Subscribe
  • Resources
  • Media Kit
  • About
  • International Access
  • Terms of Use
  • Privacy Statement
  • FAQ
  • AAP.org
  • shopAAP
  • Follow American Academy of Pediatrics on Instagram
  • Visit American Academy of Pediatrics on Facebook
  • Follow American Academy of Pediatrics on Twitter
  • Follow American Academy of Pediatrics on Youtube
  • RSS
American Academy of Pediatrics

© 2021 American Academy of Pediatrics